We are doing science for policy
The Joint Research Centre (JRC) is the European Commission's science and knowledge service which employs scientists to carry out research in order to provide independent scientific advice and support to EU policy.
The European Society of Toxicology In Vitro (ESTIV) is a leading organisation in Europe committed to promoting in vitro toxicology, strengthening networking and knowledge sharing, and advancing education and research in the field of alternative methods. This ESTIV 2016 congress - the 19th International Congress on In Vitro Toxicology for Safety Assessment - will emphasise how new technologies can strengthen the interpretation and application of in vitro methods in toxicological research and risk assessment.
The JRC's EURL ECVAM will have a strong and active presence at ESTIV 2016 with JRC researchers being involved in many different sessions including:
• The public debate session on the regulatory application of Integrated Approaches to Testing and Assessment
• Organisation of the pre-conference workshop on moving carcinogenicity assessment forward
• Informing stakeholders about a new screening methodology for identification of endocrine disrupting substances, co-developed by the JRC
• Chairing and contributing to a session on novel approaches for assessing combined effects from exposure to multiple chemicals
• Promoting a Toxicokinetics Strategy for individual and combined exposure to chemicals highlighting In vitro to In vivo Extrapolation
• Updating the community about progress made in regulatory acceptance of non-classical methods in the skin sensitisation
• Sharing the latest developments around the OECD Adverse Outcome Pathway Knowledge Base
EURL ECVAM will also be present with a stand in the ESTIV 2016 exhibition where a whole range of activities will take place to facilitate informal engagement between JRC scientists and conference participants. So come along and see us if you plan to attend ESTIV 2016 !